Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals

Heart

Volumn 98, Issue 7, 2012, Pages

  Alfonso, Fernando ^a   Timmis, Adam ^b   Pinto, Fausto J ^c   Ambrosio, Giuseppe ^d   Ector, Hugo ^e   Kulakowski, Piotr ^f   Vardas, Panos ^g  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b LONDON CHEST HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LISBON   (Portugal)

^d UNIVERSITY OF PERUGIA   (Italy)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f GROCHOWSKI HOSPITAL   (Poland)

^g UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CONFLICT OF INTEREST; CROSS-SECTIONAL STUDY; EUROPE; INFORMATION PROCESSING; INTERNET; INTERPERSONAL COMMUNICATION; MEDICAL LITERATURE; MEDICAL SOCIETY; PEER REVIEW; POLICY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW;

AUTHORSHIP; CARDIOLOGY; CONFLICT OF INTEREST; DISCLOSURE; EDITORIAL POLICIES; EUROPE; HUMANS; SOCIETIES, MEDICAL;

EID: 84858598880     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-301875     Document Type: Review

References (49)

1. International Committee of Medical Journals Editors. Uniform Requirements for Manuscript Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication. 2008. http://www.icmje.org/
2. Council of Science Editors. CSE's White Paper on Promoting Integrity in Scientific Journal Publications. Editorial policy committee, 2005-2006. http://www. CouncilScienceEditors.org
3. World Association of Medical Editors. WAME recommendations on Publication Ethics and Policies for Medical Journals. http://www.wame.org/resources/ ethicsresources
4. Committee On Publication Ethics (COPE). Code of Conduct and Best Practice Guidelines for Journal Editors. http://publication-ethics.org/resources/ guidelines
5. Alfonso F, Bermejo J, Segovia J. New recommendations of the international committee of medical journal editors. Shifting focus: from uniformity in technical requirements to bioethical considerations. Rev Esp Cardiol 2004;57:592-3. (Pubitemid 38997120)
6. Blum JA, Freeman K, Dart RC, et al. Requirements and definitions in conflict of interest policies of medical journals. JAMA 2009;302:2230-4.
7. Cooper RJ, Gupta M, Wilkes MS, et al. Conflict of interest disclosure policies and practices in peer-reviewed biomedical journals. J Gen Intern Med 2006;21:1248-52. (Pubitemid 44665332)
8. Bekelman JE, Li YL, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003;289:454-65. (Pubitemid 36119966)
9. DeAngelis CD, Fontanarosa PB. Resolving unreported conflicts of interest. JAMA 2009;302:198-9.
10. Studdert DM, Mello MM, Phil M, et al. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry. Self-regulation in the shadow of federal prosecution. N Engl J Med 2004;351:1891-900. (Pubitemid 39426326)
11. Drazen JM, Van der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. N Engl J Med 2009;361:1896-7.
12. Drazen JM, de Leeuw PW, Laine C, et al. Toward more uniform conflict disclosuresdThe updated ICMJE conflict of interest reporting form. N Engl J Med 2010;363:188-9.
13. Alfonso F, Ambrosio G, Pinto FJ, et al. European National Society cardiovascular journals. Background, rationale and mission statement of the "Editors' Club". Rev Esp Cardiol 2008;61:644-50. (Pubitemid 351930576)
14. Alfonso F, Ambrosio G, Pinto FJ, et al Editors' Network ESC Task Force. European Society of Cardiology national cardiovascular journals: the 'editors' network'. Eur Heart J 2010;31:26-8.
15. Mills P, Timmis A, Huber K, et al. The role of European national journals in education. Heart 2009;95:e3.
16. Alfonso F. The editors' network of the European society of Cardiology. Eur Heart J 2011;32:919-21.
17. Schwartz RS, Curfman GD, Morrissey S, et al. Full disclosure and the funding of biomedical research. N Engl J Med 2008;358:1850-1. (Pubitemid 351581199)
18. Simone J. More interest in conflicts of interest. Lancet Oncol 2009;10:836-7.
19. Conti RC. Conflict of interest. Clin Cardiol 2009;32:666-7.
20. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research and role of sponsors in funded studies. JAMA 2005;294:110-11. (Pubitemid 41002847)
21. Alpert JS. Doctors and the drug industry: how can we handle potential conflicts of interest? Am J Med 2005;118:99-100. (Pubitemid 40202851)
22. Alpert JS. Doctors and the drug-industry: further thoughts for dealing with potential conflicts of interest? Am J Med 2008;121:253-5. (Pubitemid 351417849)
23. Lanier WL. Bidirectional conflicts of interest involving industry and medical journals: who will champion integrity? Mayo Clin Proc 2009;84:771-5.
24. Bove A. Relations with industry: thoughts on claims of a broken system. J Am Coll Cardiol 2009;54:177-9.
25. Bodenheimer T. The uneasy alliance: clinical investigators and the pharmaceutical industry. N Engl J Med 2000;342:1539-44. (Pubitemid 30318291)
26. Goldacre B. Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes. BMJ 2009;339:b4949.
27. Davidoff F, de Angelis CD, Drazen JM, et al; International committee of medical Journal Editors. Sponsorship, authorship and accountability. Lancet 2001;358:854-6.
28. Johns MM, Barners M, Florencio PS. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust. JAMA 2003;289:741-6. (Pubitemid 37430369)
29. Alfonso F, Segovia J, Heras M, et al. Publication of clinical trials in scientific journals: editorial issues. Rev Esp Cardiol 2006;59:1206-14. (Pubitemid 46139222)
30. Patsopoulos NA, Analatos AA, Ioannidis JP. Origin and funding of the most frequently cited papers in medicine: database analysis. BMJ 2006;332:1061-4.
31. Lexchin J, Bero LA, Djulbegovic B, et al. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70. (Pubitemid 36649048)
32. Finucane TE, Boult CE. Association of funding and findings of pharmaceutical research at a meeting of a medical professional society. Am J Med 2004;117:842-5. (Pubitemid 39602793)
33. Hirsch LJ. Conflicts of interest, authorship, and disclosures in industry-related scientific publications: the tort bar and editorial oversight of medical journals. Mayo Clin Proc 2009;84:811-21.
34. Krzyanowska MK, Pintilie M, Tannock IF. Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 2003;290:495-501. (Pubitemid 37430503)
35. Chan AW, Krleza-Jerić K, Schmid I, et al. Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 2004;171:735-40. (Pubitemid 39319090)
36. Alfonso F, Bermejo J, Segovia J, et al. Duplicate or redundant publication: can we afford it? Rev Esp Cardiol 2005;58:601-4. (Pubitemid 40894730)
37. Hirsch L. Randomized clinical trials: what gets published, and when? CMAJ 2004;170:481-3. (Pubitemid 38293643)
38. Kjaergard LL, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 2002;325:249.
39. Ridker PM, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for profit and not-for-profit organizations: 2000-2005. JAMA 2006;295:2270-4. (Pubitemid 43736577)
40. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editors practices and authors disclosures. Sci Eng Ethics 2001;7:205-18. (Pubitemid 33682037)
41. Ancker JS, Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in different scientific disciplines. Sci Eng Ethics 2007;13:147-57.
42. Weinfurt KP, Seils DM, Tzeng JP, et al. Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents. PLoS ONE 2008;3:e2128.
43. Smith R. Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med 2005;2:e138.
44. Anon. Publishing commentary by authors with potential conflicts of interest: when, why and how. Ann Intern Med 2004;141:73-4.
45. Vorobiof G. Do conflict of interest really matter or does no one read the fine print anyway? J Am Coll Cardiol 2008;51:1911. (Pubitemid 351615260)
46. Tanne JH. US Senate committee investigates conflicts of interest in industry funded medical education. BMJ 2004;339:b3139.
47. Rothman KJ. Conflict of interest. The new McCarthyism in science. JAMA 1993;269:2782-4. (Pubitemid 23154255)
48. Avanzas P, Bayes-Genis A, Pe rez de Isla L, et al. Ethical considerations in the publication of scientific articles. Rev Esp Cardiol 2011;64:427-9.
49. ESC Statement on COI policy. European Heart Journal, Published Online First: March 1st 2012. doi:10.1093/-rheartj/-hr464